Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationCurrent Price
as of Oct 18, 2024$1.21
P/E Ratio
N/A
Market Cap
$72.85M
Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its pipeline includes Immuno-oncology, CUE-100 framework, CUE-200 framework, and autoimmune disease. The company was founded by Ronald D. Seidel III, Steven Almo, and Rodolfo Chaparro on December 31, 2014 and is headquartered in Boston, MA.
Overview
Trading Information
Company